Table 3 |
||||||
|
Tumour and stromal TSP expression in correlation with MVD, VEGF expression and ECM components |
||||||
|
tumour cells TSP |
stromal TSP |
|||||
|
0,1/2,3 |
p value |
0/+,++, +++ |
p value |
|||
|
|
||||||
|
mvd |
||||||
|
low |
57 |
3 |
p < 0.000 |
36 |
24 |
p = 0.031 |
|
high |
55 |
5 |
1 |
23 |
37 |
|
|
VEGF |
||||||
|
low(0,1) |
30 |
2 |
NS |
24 |
8 |
p = 0.001 |
|
high (2,3) |
100 |
8 |
51 |
56 |
||
|
p53 |
||||||
|
<5% |
40 |
5 |
NS |
37 |
17 |
NS |
|
>5% |
44 |
4 |
29 |
19 |
||
|
tenascin |
||||||
|
0,+ |
70 |
6 |
NS |
56 |
19 |
p < 0.000 |
|
++,+++ |
23 |
3 |
9 |
17 |
1 |
|
|
fibronectin |
||||||
|
0,+ |
39 |
3 |
NS |
32 |
10 |
p = 0.003 |
|
++,+++ |
54 |
6 |
33 |
26 |
||
|
|
||||||
|
Ioachim et al. BMC Cancer 2006 6:140 doi:10.1186/1471-2407-6-140 |
||||||
